NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · Real-Time Price · USD
4.390
+0.830 (23.31%)
At close: Nov 4, 2024, 4:00 PM
3.920
-0.470 (-10.71%)
After-hours: Nov 4, 2024, 7:59 PM EST
NLS Pharmaceutics AG Employees
As of December 31, 2021, NLS Pharmaceutics AG had 7 total employees, including 6 full-time and 1 part-time employees.
Employees
7
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$942,161
Market Cap
8.33M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2021 | 7 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Universe Pharmaceuticals INC | 225 |
Zhongchao | 142 |
Check-Cap | 85 |
Aptose Biosciences | 36 |
Healthcare Triangle | 31 |
Organovo Holdings | 20 |
TFF Pharmaceuticals | 19 |
Moleculin Biotech | 18 |
NLSP News
- 20 hours ago - NLS Pharmaceutics and Kadimastem Enter into a Definitive Merger Agreement - Accesswire
- 7 days ago - NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements - Accesswire
- 14 days ago - NLS Pharmaceutics Secures Key Patent in Japan for Mazindol ER in the Treatment of Heroin Dependence - Accesswire
- 20 days ago - NLS Pharmaceutics Ltd. Announces Closing of Private Placement and Expected Compliance with Nasdaq Continued Listing Rules - Accesswire
- 5 weeks ago - NLS Pharmaceutics Ltd. Announces Expected Implementation of 1-for-40 Reverse Share Split - Accesswire
- 3 months ago - Crude Oil Moves Lower; NLS Pharmaceutics Shares Jump - Benzinga
- 3 months ago - NLS Pharmaceutics and Kadimastem Announce Binding Term Sheet to Merge - Accesswire
- 4 months ago - NLS Pharmaceutics Announces Registered Direct Offering - Accesswire